Carbapenem-Resistant Enterobacteriaceae Infection Clinical Trials

24 clinical trials for Carbapenem-Resistant Enterobacteriaceae Infection across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children — RECRUITING
• Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia. — RECRUITING
• Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated Animals — RECRUITING · NA
• Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection — RECRUITING · NA
• Safety and Efficacy of Fecal Microbiota Transplantation — RECRUITING · NA
• EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics — RECRUITING · PHASE4
• Genomic and Phenotypic Diversity of Carbapenemase-producing Escherichia Coli Strains Circulating in Southern France — NOT_YET_RECRUITING
• Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae — NOT_YET_RECRUITING · NA
• Microbiological and Clinical Characteristics of Severe Infections Caused by Carbapenem-Resistant Enterobacterales — NOT_YET_RECRUITING
• The Effect of Fecal Microbiota Transplantation on the Decolonization of Multidrug-resistant Organisms — COMPLETED
• Community-associated Highly-Resistant Enterobacterales — COMPLETED
• A Novel Approach to Antimicrobial Resistance: Machine Learning Predictions for Carbapenem-Resistant Klebsiella in ICUs — COMPLETED
• Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections — WITHDRAWN · PHASE4
• Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections — TERMINATED · PHASE3
• Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections — TERMINATED · NA
• Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients — OTHER
• Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK Model — NOT_YET_RECRUITING
• Drug Resistance Mechanism of Enterobacteriaceae and Its Strategies — OTHER · NA
• Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae — COMPLETED · PHASE2
• Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae — COMPLETED · PHASE2
• Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems — TERMINATED · PHASE2
• Impact of Ceftazidime / Avibactam Treatment vs Better Available Therapy on Mortality of Patients With Infections Caused by Carbapenem-resistant Enterobacteria — COMPLETED
• Oral Capsule Faecal Microbiota Transplantation for CPE Decolonization — OTHER · PHASE2
• Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae — OTHER · NA

Refine this search